With the rising incidence of skin diseases, the demand for muscle relaxant drugs is surging sharply across the world. Some of the major factors fueling the incidence of these diseases are the increasing pollution levels, the excessive exposure to ultraviolet (UV) radiation, and increasing tobacco and alcohol consumption. Moreover, exposure to UV rays causes reduction in skin elasticity and also makes the skin highly vulnerable to sunburns, thereby pushing up the requirement for muscle relaxant drugs.

Apart from the aforementioned factor, the rising prevalence of acne is also powering the sales of muscle relaxant drugs around the world. This is because botulinum toxin-based muscle relaxant procedures are required for treating this disease. The surging spending spending on various facial aesthetic treatment procedures, on account of the growing disposable income of people, and the soaring usage of neuromuscular blocking agents in surgery are also powering the sales of these drugs.

Due to the above-mentioned factors, the global muscle relaxant drugs market is expected to exhibit huge expansion in the coming years. Neuromuscular blocking agents, skeletal muscle relaxants, and facial aesthetic relaxants are the most widely used types of muscle relaxant drugs. Amongst these, the demand for these relaxants was found to be the highest during the last few years. Moreover, the sales of these relaxants are predicted to rise rapidly in the upcoming years.

This will be because of the high efficiency and safety of these relaxants. Botox and disport are the two most commonly used facial aesthetic relaxant drugs across the world. Between these two, the sales of the botox drugs were found to be higher in the past years, and this trend will continue in the coming years as well, as per the estimates of PS Intelligence, a market research company based in India.

Geographically, the demand for muscle relaxant drugs was observed to be the highest in North America in the years gone by. This was because of the large-scale usage of facial muscle relaxants and the existence of a large geriatric population in the region. On the other hand, in the upcoming years, the sales of drugs drugs will shoot up in Asia, these excellence due to the rapidly improving infrastructure and the increasing volume of surgery being performed in the region.

Hence, it can be said without any hesitation that the demand for muscle relaxant drugs will rise enormously in the years to come, preeminent because of the growing incidence of skin diseases and the ballooning population of aging people all over the world.